Login to Your Account

Financings Roundup

Fat $34M Series A Launches Start-Up Obesity Firm Ember

By Catherine Shaffer
BioWorld Today Contributing Writer

Thursday, December 15, 2011

Third Rock Ventures LLC said today the newest member of its portfolio, Ember Therapeutics, launched with a $34 million Series A financing. Ember will focus on discovery and development of obesity and diabetes therapeutics based on brown fat biology and new science relating to insulin sensitivity.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription